Related references
Note: Only part of the references are listed.TRIM-NHL proteins in development and disease
Cristina Tocchini et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
ChAMP: 450k Chip Analysis Methylation Pipeline
Tiffany J. Morris et al.
BIOINFORMATICS (2014)
The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation
Gaurav Kumar Pandey et al.
CANCER CELL (2014)
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas
Daniel Dreidax et al.
HUMAN MOLECULAR GENETICS (2014)
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
Pedro Castelo-Branco et al.
LANCET ONCOLOGY (2013)
Identification of aberrant methylation regions in neuroblastoma by screening of tissue-specific differentially methylated regions
Kiminobu Sugito et al.
PEDIATRIC BLOOD & CANCER (2013)
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
H. Kocak et al.
CELL DEATH & DISEASE (2013)
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
Anna Djos et al.
MOLECULAR CANCER (2012)
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
Anneleen Decock et al.
GENOME BIOLOGY (2012)
Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
Helena Caren et al.
BMC CANCER (2011)
High density DNA methylation array with single CpG site resolution
Marina Bibikova et al.
GENOMICS (2011)
Genome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions
Patrick G. Buckley et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines
Qiwei Yang et al.
BMC CANCER (2010)
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
Helena Caren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TRIM36 interacts with the kinetochore protein CENP-H and delays cell cycle progression
Naoto Miyajima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Aberrant methylation of candidate tumor suppressor genes in neuroblastoma
Jasmien Hoebeeck et al.
CANCER LETTERS (2009)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
TRPV1 expression and activity during retinoic acid-induced neuronal differentiation
Johanna El Andaloussi-Lilja et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
Helena Caren et al.
BIOCHEMICAL JOURNAL (2008)
High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors:: Four cases of homozygous deletions of the CDKN2A gene
Helena Caren et al.
BMC GENOMICS (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
Oncogenic mutations of ALK kinase in neuroblastoma
Yuyan Chen et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis
Masanobu Abe et al.
ONCOLOGY (2008)
Genetic and epigenetic changes in the common Ip36 deletion in neuroblastoma tumours
H. Caren et al.
BRITISH JOURNAL OF CANCER (2007)
Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma
M Alaminos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
The human genome browser at UCSC
WJ Kent et al.
GENOME RESEARCH (2002)
Share Paper
